|
| 36239575 | Cancer Incidence and Etiology in the Active Duty Population of U.S. Military. | Mil Med | 2024 |
| 37851358 | Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System. | Am J Clin Oncol | 2024 |
| 38038766 | Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer. | Breast Cancer Res Treat | 2024 |
| 37725334 | Cancer incidence in the US military: An updated analysis. | Cancer | 2024 |
| 37532916 | Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status. | Cancer Causes Control | 2024 |
| 34296267 | Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System. | Mil Med | 2023 |
| 37902129 | Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry. | Cancer Med | 2023 |
| 37481512 | Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data. | BMC Bioinformatics | 2023 |
| 37582239 | MilCanEpi: Increased Capability for Cancer Care Research in the Department of Defense. | JCO Clin Cancer Inform | 2023 |
| 37088463 | Quantile Index Biomarkers Based on Single-Cell Expression Data. | Lab Invest | 2023 |
| 37167011 | Chemotherapy Treatment Costs and Clinical Outcomes of Colon Cancer in the U.S. Military Health System's Direct and Private Sector Care Settings. | Mil Med | 2023 |
| 37067801 | Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. | JAMA Netw Open | 2023 |
| 36652667 | High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. | JCO Precis Oncol | 2023 |
| 36781807 | Use of Longitudinal Serum Analysis and Machine Learning to Develop a Classifier for Cancer Early Detection. | Methods Mol Biol | 2023 |
| 36609596 | Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population. | Br J Cancer | 2023 |
| 36833598 | Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer. | Int J Environ Res Public Health | 2023 |
| 36571909 | Cancers of unknown primary: Survival by histologic type, demographic features, and treatment in the U.S. Military Health System. | Cancer Epidemiol | 2023 |
| 36942312 | Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System. | Health Equity | 2023 |
| 33990095 | Incidence rates of oral cavity and oropharyngeal cancers among men: a comparison of active-duty military and general populations. | Eur J Cancer Prev | 2022 |
| 35409765 | Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients. | Int J Environ Res Public Health | 2022 |
| 35838810 | The relationship between prior psychiatric diagnosis and brain cancer diagnosis in the U.S. military health system. | Cancer Causes Control | 2022 |
| 35727910 | Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program. | J Am Acad Orthop Surg Glob Res Rev | 2022 |
| 35530653 | Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients. | Cancer Diagn Progn | 2022 |
| 35624045 | Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. | Gynecol Oncol | 2022 |
| 35868102 | Influence of germline test results on surgical decision making in women with invasive breast cancer. | Cancer Genet | 2022 |
| 36384096 | Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. | Cell Rep Med | 2022 |
| 36091166 | Eligibility, uptake and response to germline genetic testing in women with DCIS. | Front Oncol | 2022 |
| 35041696 | Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure. | PLoS One | 2022 |
| 34906450 | Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system. | Genet Med | 2022 |
| 35053472 | Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. | Cancers (Basel) | 2022 |
| 34961733 | Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program. | Clin Breast Cancer | 2022 |
| 32898014 | Brain cancer incidence: a comparison of active-duty military and general populations. | Eur J Cancer Prev | 2021 |
| 33706355 | Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System. | Obstet Gynecol | 2021 |
| 35036865 | Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. | iScience | 2021 |
| 34547444 | Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program. | Ann Epidemiol | 2021 |
| 34397617 | Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population. | J Pediatr Hematol Oncol | 2021 |
| 34478468 | Incidence rates of digestive cancers among U.S. military servicemen: Comparison with the rates in the general U.S. population. | PLoS One | 2021 |
| 34129457 | Philadelphia Prostate Cancer Genetic Consensus Conference 2019 and implications for military medicine. | Can J Urol | 2021 |
| 34325938 | Racial disparities in survival among women with endometrial cancer in an equal access system. | Gynecol Oncol | 2021 |
| 34278265 | Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. | iScience | 2021 |
| 34162655 | Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33083949 | Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer. | Fam Cancer | 2021 |
| 33128553 | Commentary on "Austere Resuscitative and Surgical Care in Support of Forward Military Operations-Joint Trauma System Position Paper". | Mil Med | 2021 |
| 33206196 | Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness. | Mil Med | 2021 |
| 32976668 | Tumour size and overall survival among surgically treated patients with non-metastatic colon cancer in the U.S. Military Health System. | Colorectal Dis | 2021 |
| 31271431 | Racial Comparisons in Timeliness of Colon Cancer Treatment in an Equal-Access Health System. | J Natl Cancer Inst | 2020 |
| 32000167 | Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer. | Am J Clin Oncol | 2020 |
| 32029291 | Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. | Gynecol Oncol | 2020 |
| 31784990 | Factors related to re-excision procedures following primary breast-conserving surgery for women with breast cancer in the U.S. Military Health System. | J Surg Oncol | 2020 |
| 31963545 | Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience. | Cancers (Basel) | 2020 |